[11B2-11B2];[11D5-11D5];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
11B2;11D5
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
1: P{XP}d06616
2: PBac{WH}CG15721f03962
The presence of P+PBac{XP5.WH5}BSC625 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(1)BSC625 predicted from the Release 5 genomic coordinates of the insertion sites of P{XP}d06616 and PBac{WH}CG15721f03962 progenitor transposable elements are 11B2;11D5.